Clinical Trial Update: A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a new eye drop formulation with OPTIVE in Dry Eye Disease has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• New Eye Drop Formulation
• Optive

Snippet

Sponsor: Allergan | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-06-08